BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma

Leukemia. 2006 Jul;20(7):1313-5. doi: 10.1038/sj.leu.2404228. Epub 2006 Apr 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Cell Activating Factor / physiology*
  • Cell Survival / physiology
  • Humans
  • Immunoglobulin Fc Fragments / genetics
  • Immunoglobulin Fc Fragments / therapeutic use
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology*
  • Osteoclasts / physiology
  • Transmembrane Activator and CAML Interactor Protein / genetics
  • Transmembrane Activator and CAML Interactor Protein / therapeutic use*
  • Tumor Necrosis Factor Ligand Superfamily Member 13 / physiology*

Substances

  • B-Cell Activating Factor
  • Immunoglobulin Fc Fragments
  • TNFSF13B protein, human
  • Transmembrane Activator and CAML Interactor Protein
  • Tumor Necrosis Factor Ligand Superfamily Member 13
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy